Brief: EQRx Posts Q4 Loss Per Share Of $0.05
23/02/2023 12:02
Feb 23 (Reuters) - EQRx Q4 operating expenses USD 100.73 million. * Q4 EPS USD -0.05 * Q4 net income USD -22.177 million
Recent news on EQRx
See all newsBrief: Leading Independent Proxy Advisory Firms ISS And Glass Lewis Recommend Revolution Medicines Stockholders Vote "FOR" Proposed Acquisition Of EQRx, Inc
Brief: Revolution Medicines Inc Says Will Acquire EQRx In An All-Stock Transaction
U.S. RESEARCH ROUNDUP- Cigna Group, McKesson, Zscaler
Brief: EQRx posts Q1 EPS USD -0.17
Brief: EQRx Says Jami Rubin Will Step Down As Chief Financial Officer